Agrifood Tech | November 3, 2017

Aqua-Spark backs aquaculture ventures Proteon Pharmaceuticals and Cryoocyte

The team at


The Dutch aquaculture fund has made 15 sustainable aquaculture investments over the last two years.

Poland-based Proteon has developed an antibiotic-free method of killing bacteria like salmonella in fish and poultry.

Aqua-Spark was the sole investor in its $4.1 million Series A round. “We’ve been looking at disease-battling companies from the beginning,” Aqua-Spark co-founder Mike Velings told AgFunderNews.

Aqua-Spark also co-led (with Vodia Ventures) the $4 million Series A round for Cryoocyte, which is working on technology for freezing fish eggs.

The technology could be important in preserving long-term biodiversity in aquaculture.